RE:RE:Not sure I wanted to bring this topic up (again.)The only 3rd party that I actually suspect being able to pull off a successful proxy fight is probably big pharma. And like I mentioned in an early post, I think it would be significantly cheaper for them to do it with a stock exchange offer to existing shareholders rather than a cash bid. Furthermore, I doubt any of us would question whether or not they could bring all that TLT is currently working on into fruition in relatively short order.